MedPacto, Inc. (235980.KQ)

KRW 4585.0

(-1.4%)

Inventory Summary of MedPacto, Inc.

MedPacto, Inc.'s latest annual inventory in 2023 was 620.00 KRW , down -15.07% from previous year.
MedPacto, Inc.'s latest quarterly inventory in 2024 Q2 was - KRW , down -100.0% from previous quarter.
MedPacto, Inc. reported annual inventory of 730.00 KRW in 2022, up 392.0% from previous year.
MedPacto, Inc. reported annual inventory of -250.00 KRW in 2021, down -126.04% from previous year.
MedPacto, Inc. reported quarterly inventory of 820.00 KRW for 2024 Q1, up 32.26% from previous quarter.
MedPacto, Inc. reported quarterly inventory of 370.00 KRW for 2023 Q3, up 362.5% from previous quarter.

Annual Inventory Chart of MedPacto, Inc. (2023 - 2017)

Historical Annual Inventory of MedPacto, Inc. (2023 - 2017)

Year	Inventory	Inventory Growth
2023	620.00 KRW	-15.07%
2022	730.00 KRW	392.0%
2021	-250.00 KRW	-126.04%
2020	960.00 KRW	0.0%
2019	- KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	0.0%

Year	Inventory	Inventory Growth
2024 Q2	- KRW	-100.0%
2024 Q1	820.00 KRW	32.26%
2023 Q3	370.00 KRW	362.5%
2023 FY	620.00 KRW	-15.07%
2023 Q4	620.00 KRW	67.57%
2023 Q2	80.00 KRW	100.0%
2023 Q1	-8.3 Billion KRW	-1137940569.86%
2022 Q4	730.00 KRW	78.05%
2022 Q2	740.00 KRW	-8.64%
2022 FY	730.00 KRW	392.0%
2022 Q1	810.00 KRW	424.0%
2022 Q3	410.00 KRW	-44.59%
2021 Q4	-250.00 KRW	-13.64%
2021 Q1	- KRW	-100.0%
2021 Q2	1.00 KRW	0.0%
2021 FY	-250.00 KRW	-126.04%
2021 Q3	-220.00 KRW	-22100.0%
2020 Q4	960.00 KRW	0.0%
2020 FY	960.00 KRW	0.0%
2019 FY	- KRW	0.0%
2018 FY	- KRW	0.0%
2017 FY	- KRW	0.0%

Peer Inventory Comparison of MedPacto, Inc.

Name	Inventory	Inventory Difference
HLB Co., Ltd.	11.42 Billion KRW	100.0%
iNtRON Biotechnology, Inc.	1.01 Billion KRW	100.0%
BINEX Co., Ltd.	28.26 Billion KRW	100.0%
Bioneer Corporation	41.35 Billion KRW	100.0%
Anterogen.Co.,Ltd.	1.91 Billion KRW	100.0%
MEDIPOST Co., Ltd.	14.51 Billion KRW	100.0%
CrystalGenomics, Inc.	1.55 Billion USD	100.0%
Helixmith Co., Ltd	914.11 Million KRW	100.0%
Chabiotech Co.,Ltd.	34.11 Billion KRW	100.0%
Medy-Tox Inc.	59.61 Billion KRW	100.0%
Peptron, Inc.	172.18 Million KRW	100.0%
Amicogen, Inc.	46.83 Billion KRW	100.0%
Genexine, Inc.	3.8 Billion KRW	100.0%
HLB Therapeutics Co.,Ltd.	5.33 Billion KRW	100.0%
LegoChem Biosciences, Inc.	196.83 Million KRW	100.0%
ALTEOGEN Inc.	1.06 Billion KRW	100.0%
PharmaResearch Co., Ltd.	50.23 Billion KRW	100.0%
SillaJen, Inc.	1.21 Billion KRW	100.0%
JETEMA, Co., Ltd.	12.74 Billion KRW	100.0%
OliX Pharmaceuticals,Inc	468.4 Million KRW	100.0%
Genomictree Inc.	496.53 Million KRW	100.0%
D&D Pharmatech	3.45 Billion KRW	100.0%
EASY BIO,Inc.	25.93 Billion KRW	100.0%
GI Innovation, Inc.	- KRW	-Infinity%